COVID-19 is a new illness that can affect your lungs and airways. It is caused by a novel coronavirus that was first detected in people in China in 2019, and has since spread to other parts of the world. The following are recommendations made by our society for patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (NMOSD) based on guidelines from international expert groups. They will be reviewed and updated as newest evidence of COVID-19 becomes available.


Recommendations for patients with MS


Recommendations for patients with NMOSD